drugset / Trial / NCT03999008

Oral Viscous Budesonide in Anastomotic Stricture After Esophageal Atresia Repair (OVB in EA)

NCT03999008

Unknown 60 enrolled St. Justine's Hospital
RandomizedParallel-groupTriple-blindPrevention

Summary

The aim of this study is to perform a multicentre, prospective, randomized, placebo controlled, double-blinded study to demonstrate the potential and beneficial effects of OVB in the prevention of recurrence of anastomotic stricture in children operated for esophageal atresia with an anastomotic stricture.

Timeline

Start
2020-06-01
Primary completion
2022-06-01
Completion
2023-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 250 ug Oral
Comparator Budesonide Small molecule 500 ug Oral
Comparator Budesonide Small molecule 1000 ug Oral

Indications